|
Home : FDA Drug Database : Aclovate : FDA Information : Drug and Device Product Approvals for April 1996 Drug and Device Product Approvals for April 1996
Drug and Device Product Approvals for April 1996***ORIGINAL AND SUPPLEMENTAL NDAs*** FOR NEW DRUG PRODUCTS19-537 CIPRO BAYER CIPROFLOXACIN HYDROCHLORIDE08-APR-96 (TABLET) WEST HAVEN, CT EQ 100MG BASE(SUPPL-026) 06516 EQ 250MG BASE EQ 500MG BASE EQ 750MG BASE (NEW INDICATION -- TREATMENT OF ACUTE UNCOMPLICATED CYSTITIS IN FEMALES)20-406 PREVACID TAP HOLDINGS LANSOPRAZOLE08-APR-96 (CAPSULE, DEERFIELD, IL 15MG(SUPPL-002) DELAYED RELEASE) 60015 30MG GRANULES (NEW INDICATION -- MAINTENANCE OF HEALING OF EROSIVE ESOPHAGITIS)50-704 DAUNOXOME NEXSTAR DAUNORUBICIN CITRATE08-APR-96 (INJECTABLE, SAN DIMAS, CA EQ 2MG BASE/ML(3 P, AA*, LIPOSOMAL) 91773 (ANTINEOPLASTIC)V**) [FIRST LINE CYTOTOXIC THERAPY FOR ADVANCED HIV RELATED KAPOSI'S SARCOMA] 19-810 PRILOSEC ASTRA MERCK OMEPRAZOLE15-APR-96 (CAPSULE, WAYNE, PA 10MG(SUPPL-037) DELAYED RELEASE) 19087 20MG GRANULES (NEW INDICATION -- COMBINATION THERAPY WITH CLARITHROMYCIN TO ERADICATE HELICOBACTER PYLORI TO REDUCE THE RISK OF DUODENAL ULCER RECURRENCE)AA* - Priority Classification AIDS DrugV** - Designated Orphan Drug20-670 MONISTAT-3 ADV CARE MICONAZOLE NITRATE16-APR-96 COMBINATION PACK RARITAN, NJ 2% CREAM(6 S) (CREAM/ 08869 200MG SUPPOSITORY SUPPOSITORY) (ANTIFUNGAL) [TREATMENT OF VULVOVAGINAL CANDIDIASIS] (OTC)50-662 BIAXIN ABBOTT CLARITHROMYCIN18-APR-96 (TABLET) ABBOTT PARK, IL 250MG(SUPPL-010) 60064 500MG (NEW INDICATION -- COMBINATION THERAPY WITH OMEPRAZOLE FOR THE TREATMENT OF PATIENTS WITH AN ACTIVE DUODENAL ULCER ASSOCIATED WITH HELICOBACTER PYLORI)18-731 BUSPAR BRISTOL MYERS BUSPIRONE HYDROCHLORIDE22-APR-96 (TABLET) SQUIBB 5MG(SUPPL-031) WALLINGFORD, CT 10MG 06492 15MG 30MG*** (NEW DOSAGE REGIMEN -- DOSING SCHEDULE CHANGED TO BID AND INITIAL DOSE CHANGED TO 7.5MG) 20-472 ESTRING PHARMACIA ESTRADIOL26-APR-96 (INSERT, COLUMBUS, OH 0.0075MG/24HR(3 S) EXTENDED RELEASE) 43216 (ESTROGEN) [TREATMENT OF UROGENITAL SYMPTOMS ASSOCIATED WITH POST-MENOPAUSAL ATROPHY OF THE VAGINA AND/OR THE LOWER URINARY TRACT]20-528 MAVIK KNOLL PHARM TRANDOLAPRIL26-APR-96 (TABLET) MOUNT OLIVE, NJ 1MG(1 S) 07828 2MG 4MG (ANGIOTENSIN CONVERTING ENZYME INHIBITOR) [TREATMENT OF HYPERTENSION]20-344 REDUX INTERNEURON DEXFENFLURAMINE29-APR-96 (CAPSULE) LEXINGTON, MA HYDROCHLORIDE(3 S) 02173 15MG (SEROTONIN REUPTAKE INHIBITOR/RELEASING AGENT) [MANAGEMENT OF OBESITY]*** - Not Marketed At This Time20-573 BUPHENYL UCYCLYD SODIUM PHENYLBUTYRATE30-APR-96 (POWDER) HUNT VALLEY, MD 3GM/TEASPOONFUL(1 P, V**) 21031 (HYPERAMMONENMIA AGENT) [MANAGEMENT OF CHRONIC UREA CYCLE DISORDERS]V** - Designated Orphan Drug ***APPROVABLE ORIGINAL NDAs***An approvable letter indicates that FDA is prepared to approve the applicationupon the satisfaction of conditions specified in the approvable letter.Drug products which are the subject of approvable letters may not be legallymarketed until the firm has satisfied the identified deficiencies, as well asany other requirements that may be imposed by FDA, and has been notified inwriting that the application has been approved. Further information onapprovable NDAs is not subject to Freedom of Information (FOI) release untilapplications are approved.20-524 BUTENAFINE HCL PENEDERM BUTENAFINE HYDROCHLORIDE03-APR-96 (CREAM) FOSTER CITY, CA 1% 94404 (ANTIFUNGAL)20-511 APHTHASOL BLOCK DRUG AMLEXANOX16-APR-96 (PASTE) JERSEY CITY, NJ 5% 07302 (ANTI-INFLAMMATORY)19-764 SAIZEN SERONO LABS SOMATROPIN, BIOSYNTHETIC22-APR-96 (INJECTABLE) NORWELL, MA 5MG/VIAL 02061 10MG/VIAL (HUMAN GROWTH HORMONE)20-589 CHILDREN'S ADVIL WHITEHALL LABS IBUPROFEN25-APR-96 (SUSPENSION) MADISON, NJ 100MG/5ML 07940 (NONSTEROIDAL ANTI-INFLAMMATORY) (OTC)20-602 JUNIOR STRENGTH MCNEIL IBUPROFEN25-APR-96 MOTRIN FT WASHINGTON, PA 100MG (TABLET) 19034 (NONSTEROIDAL ANTI-INFLAMMATORY) (OTC) 20-603 CHILDREN'S MOTRIN MCNEIL IBUPROFEN25-APR-96 (SUSPENSION) FT WASHINGTON, PA 40MG/ML 19034 (NONSTEROIDAL ANTI-INFLAMMATORY) (OTC) 20-591 TARKA KNOLL PHARM TRANDOLAPRIL26-APR-96 (TABLET) MOUNT OLIVE, NJ 2MG 07828 (ANGIOTENSIN CONVERTING ENZYME INHIBITOR) VERAPAMIL HYDROCHLORIDE 180MG (CALCIUM CHANNEL BLOCKER)20-591 TARKA KNOLL PHARM TRANDOLAPRIL26-APR-96 (TABLET) MOUNT OLIVE, NJ 4MG 07828 (ANGIOTENSIN CONVERTING ENZYME INHIBITOR) VERAPAMIL HYDROCHLORIDE 240MG (CALCIUM CHANNEL BLOCKER) ***ORIGINAL ABBREVIATED NDAs***20-345* AMINOSYN-HF 8% ABBOTT AMINO ACIDS04-APR-96 (INJECTABLE) ABBOTT PARK, IL 8% 60064 (NUTRIENT REPLENISHER)20-360* HEPATASOL 8% BAXTER AMINO ACIDS04-APR-96 (INJECTABLE) ROUND LAKE, IL 8% 60073 (NUTRIENT REPLENISHER)74-588* MINOXIDIL BARRE MINOXIDIL05-APR-96 (FOR MEN) BALTIMORE, MD 2% (SOLUTION) 21224 (HAIR GROWTH STIMULANT)74-589* MINOXIDIL LEMMON MINOXIDIL05-APR-96 (FOR MEN) SELLERSVILLE, PA 2% (SOLUTION) 18960 (HAIR GROWTH STIMULANT)74-643 MINOXIDIL BAUSCH AND LOMB MINOXIDIL09-APR-96 (FOR MEN) TAMPA, FL 2% (SOLUTION) 33637 (HAIR GROWTH STIMULANT)73-667 NORTRIPTYLINE HCL BIOCRAFT NORTRIPTYLINE HYDROCHLORIDE11-APR-96 (CAPSULE) FAIR LAWN, NJ EQ 10MG BASE 07410 EQ 25MG BASE EQ 50MG BASE EQ 75MG BASE (ANTIDEPRESSANT) 74-216 NAPROXEN BIOCRAFT NAPROXEN11-APR-96 (TABLET) FAIR LAWN, NJ 250MG 07410 375MG 500MG (NONSTEROIDAL ANTI-INFLAMMATORY)40-157 HYDROCODONE VINTAGE PHARMS ACETAMINOPHEN12-APR-96 BITARTRATE AND CHARLOTTE, NC 750MG ACETAMINOPHEN 28206 HYDROCODONE BITARTRATE (TABLET) 7.5MG (ANALGESIC)40-086* UNIPHYL PURDUE FREDERICK THEOPHYLLINE15-APR-96 (TABLET, NORWALK, CT 600MG EXTENDED RELEASE) 06850 (BRONCHODILATOR)* - First Time Product Available Generically40-118* CARISOPRODOL, EON LABS ASPIRIN16-APR-96 ASPIRIN AND LAURELTON, NY 325MG CODEINE PHOSPHATE 11413 CARISOPRODOL (TABLET) 200MG CODEINE PHOSPHATE 16MG (ANALGESIC/ SKELETAL MUSCLE RELAXANT)74-576 CAPTOPRIL CHELSEA LABS CAPTOPRIL23-APR-96 (TABLET) CINCINNATI, OH 12.5MG 45215 25MG 50MG 100MG (ANGIOTENSIN CONVERTING ENZYME INHIBITOR)40-092* DIGOXIN PEDIATRIC SANOFI WINTHROP DIGOXIN25-APR-96 (INJECTABLE) NEW YORK, NY 0.1MG/ML 10016 (ANTIARRHYTHMIC/ CARDIOTONIC)40-116 CARISOPRODOL EON LABS ASPIRIN25-APR-96 AND ASPIRIN LAURELTON, NY 325MG (TABLET) 11413 CARISOPRODOL 200MG (ANALGESIC/ SKELETAL MUSCLE RELAXANT)74-428 CIMETIDINE HCL MOVA CIMETIDINE HYDROCHLORIDE25-APR-96 (INJECTABLE) CAGUAS, PR EQ 300MG BASE/2ML 00755 (HISTAMINE H-2 RECEPTOR ANTAGONIST)40-119 ACETAMINOPHEN AND HI TECH PHARMA ACETAMINOPHEN26-APR-96 CODEINE PHOSPHATE AMITYVILLE, NY 120MG/5ML (SOLUTION) 11701 CODEINE PHOSPHATE 12MG/5ML (ANALGESIC)73-531 POTASSIUM CHLORIDE BIOCRAFT POTASSIUM CHLORIDE26-APR-96 (CAPSULE, ELMWOOD PARK, NJ 8MEQ EXTENDED RELEASE) 07407 (ELECTROLYTE REPLACEMENT)73-532 POTASSIUM CHLORIDE BIOCRAFT POTASSIUM CHLORIDE26-APR-96 (CAPSULE, FAIR LAWN, NJ 10MEQ EXTENDED RELEASE) 07410 (ELECTROLYTE REPLACEMENT)* - First Time Product Available Generically74-026 TRIAMTERENE AND SIDMAK LABS NJ HYDROCHLOROTHIAZIDE26-APR-96 HYDROCHLOROTHIAZIDE EAST HANOVER, NJ 25MG (TABLET) 07936 TRIAMTERENE 37.5MG (DIURETIC)74-299*+ INDAPAMIDE ZENITH GOLDLINE INDAPAMIDE29-APR-96 (TABLET) NORTHVALE, NJ 1.25MG 07647 (NEW STRENGTH)* - First Time Product Available Generically+ - Supplemental Abbreviated NDA ***ORIGINAL ABBREVIATED AND 505(b)(2) NDAs WITH TENTATIVE APPROVAL***A tentative approval indicates that FDA has given an abbreviated new drugapplication (ANDA) or 505(b)(2) application provisional approval under theterms of the Drug Price Competition and Patent Term Restoration Act. Suchdrugproducts that are the subjects of tentative approvals may not be legallymarketed until the market exclusivity and/or patent term of the listedreference drug product has expired. Final approval is also contingent uponconditions and information available to FDA remaining acceptable. When theapplication receives final approval, the product may be legally marketed. Theeffective approval date will be listed in this publication and in the"Approved Drug Products with Therapeutic Equivalence Evaluations" listpublished by FDA. Additional information on these applications will become available to thepublic when the applications receive final approval. THERE ARE NO ORIGINAL ABBREVIATED AND 505(b)(2) NDAs WITH TENTATIVE APPROVALFOR APRIL 1996. ***LABELING SUPPLEMENTS TO ORIGINAL NDAs***20-262 TAXOL BRISTOL MYERS SQUIBB PACLITAXEL01-APR-96 (INJECTABLE) WALLINGFORD, CT 6MG/ML 06492 (LABELING REVISION -- BOXED WARNING; DESCRIPTION; WARNINGS; PRECAUTIONS; ADVERSE REACTIONS; DOSAGE AND ADMINISTRATION; HOW SUPPLIED)18-602 CARDIZEM HOECHST MARION RSSL DILTIAZEM HYDROCHLORIDE02-APR-96 (TABLET) KANSAS CITY, MO 30MG 64134 60MG 90MG 120MG (LABELING REVISION -- WARNINGS; ADVERSE REACTIONS; OVERDOSAGE)19-951 RETROVIR GLAXO WELLCOME ZIDOVUDINE02-APR-96 (INJECTABLE) RES TRIANGLE PK, NC 10MG/ML 27709 (LABELING REVISION -- CLINICAL PHARMACOLOGY; INDICATIONS AND USAGE; WARNINGS; PRECAUTIONS; ADVERSE REACTIONS; OVERDOSAGE; DOSAGE AND ADMINISTRATION)20-027 CARDIZEM HOECHST MARION RSSL DILTIAZEM HYDROCHLORIDE02-APR-96 (INJECTABLE) KANSAS CITY, MO 5MG/ML 64134 25MG/VIAL (LABELING REVISION -- ADVERSE REACTIONS)20-033 LOTENSIN HCT CIBA BENAZEPRIL HYDROCHLORIDE02-APR-96 (TABLET) SUMMIT, NJ 5MG 07901 HYDROCHLOROTHIAZIDE 6.25MG (LABELING REVISION -- INDICATIONS AND USAGE; PRECAUTIONS; ADVERSE REACTIONS)20-033 LOTENSIN HCT CIBA BENAZEPRIL HYDROCHLORIDE02-APR-96 (TABLET) SUMMIT, NJ 10MG 07901 HYDROCHLOROTHIAZIDE 12.5MG (LABELING REVISION -- INDICATIONS AND USAGE; PRECAUTIONS; ADVERSE REACTIONS)20-033 LOTENSIN HCT CIBA BENAZEPRIL HYDROCHLORIDE02-APR-96 (TABLET) SUMMIT, NJ 20MG 07901 HYDROCHLOROTHIAZIDE 12.5MG (LABELING REVISION -- INDICATIONS AND USAGE; PRECAUTIONS; ADVERSE REACTIONS)20-033 LOTENSIN HCT CIBA BENAZEPRIL HYDROCHLORIDE02-APR-96 (TABLET) SUMMIT, NJ 20MG 07901 HYDROCHLOROTHIAZIDE 25MG (LABELING REVISION -- INDICATIONS AND USAGE; PRECAUTIONS; ADVERSE REACTIONS)20-062 CARDIZEM CD CARDERM DILTIAZEM HYDROCHLORIDE02-APR-96 (CAPSULE, HAMILTON, BERMUDA 120MG EXTENDED RELEASE) 180MG 240MG 300MG (LABELING REVISION -- WARNINGS; ADVERSE REACTIONS; OVERDOSAGE)17-892 HALCION UPJOHN TRIAZOLAM04-APR-96 (TABLET) KALAMAZOO, MI 0.125MG 49001 0.25MG (LABELING REVISION -- CONTRAINDICATIONS; WARNINGS; PRECAUTIONS; PATIENT PACKAGE INSERT)18-584 BECONASE GLAXO WELLCOME BECLOMETHASONE DIPROPIONATE04-APR-96 (AEROSOL, METERED) RES TRIANGLE PK, NC 0.042MG/INH 27709 (LABELING REVISION -- PRECAUTIONS; ADVERSE REACTIONS)50-668 LORABID LILLY LORACARBEF05-APR-96 (CAPSULE) INDIANAPOLIS, IN 200MG 46285 400MG (LABELING REVISION -- SECTION(S) OF LABELING REVISED NOT SPECIFIED IN APPROVAL LETTER) 16-099 ATROMID-S WYETH AYERST CLOFIBRATE08-APR-96 (CAPSULE) PHILADELPHIA, PA 500MG 19101 (LABELING REVISION -- WARNINGS; PRECAUTIONS; ADVERSE REACTIONS)19-537 CIPRO BAYER CIPROFLOXACIN HYDROCHLORIDE08-APR-96 (TABLET) WEST HAVEN, CT EQ 100MG BASE 06516 EQ 250MG BASE EQ 500MG BASE EQ 750MG BASE (LABELING REVISION -- INDICATIONS AND USAGE)20-406 PREVACID TAP HOLDINGS LANSOPRAZOLE08-APR-96 (CAPSULE, DEERFIELD, IL 15MG DELAYED RELEASE 60015 30MG GRANULES) (LABELING REVISION -- INDICATIONS AND USAGE)18-920* MVI PEDIATRIC ASTRA ASCORBIC ACID09-APR-96 (INJECTABLE) WESTBOROUGH, MA 80MG/VIAL 01581 BIOTIN 20MCG/VIAL CYANOCOBALAMIN 1MCG/VIAL DEXPANTHENOL 5MG/VIAL ERGOCALCIFEROL 10MCG/VIAL FOLIC ACID 140MCG/VIAL NIACINAMIDE 17MG/VIAL PHYTONADIONE 200MCG/VIAL PYRIDOXINE HYDROCHLORIDE EQ 1MG BASE/VIAL RIBOFLAVIN PHOSPHATE SODIUM EQ 1.4MG BASE/VIAL THIAMINE HYDROCHLORIDE EQ 1.2MG BASE/VIAL VITAMIN A 0.7MG/VIAL VITAMINE E 7MG/VIAL (LABELING REVISION -- ADVERSE REACTIONS)16-832 CYLERT ABBOTT PEMOLINE11-APR-96 (TABLET) ABBOTT PARK, IL 18.75MG 60064 37.5MG 75MG (LABELING REVISION -- OVERDOSAGE)17-703 CYLERT ABBOTT PEMOLINE11-APR-96 (TABLET, CHEWABLE) ABBOTT PARK, IL 37.5MG 60064 (LABELING REVISION -- OVERDOSAGE) * - Not Marketed At This Time19-885 ACCUPRIL PARKE DAVIS QUINAPRIL HYDROCHLORIDE12-APR-96 (TABLET) MORRIS PLAINS, NJ EQ 5MG BASE 07950 EQ 10MG BASE EQ 20MG BASE EQ 40MG BASE (LABELING REVISION -- INDICATIONS AND USAGE; WARNINGS; ADVERSE REACTIONS)09-053 PURINETHOL GLAXO WELLCOME MERCAPTOPURINE15-APR-96 (TABLET) RES TRIANGLE PK, NC 50MG 27709 (LABELING REVISION -- WARNINGS)19-810 PRILOSEC ASTRA MERCK OMEPRAZOLE15-APR-96 (CAPSULE, WAYNE, PA 10MG DELAYED RELEASE 19087 20MG GRANULES) (LABELING REVISION -- CLINICAL PHARMACOLOGY; INDICATIONS AND USAGE; CONTRAINDICATIONS; PRECAUTIONS; ADVERSE REACTIONS; DOSAGE AND ADMINISTRATION)19-084 NIZORAL JANSSEN KETOCONAZOLE16-APR-96 (CREAM) TITUSVILLE, NJ 2% 08569 (LABELING REVISION -- ADVERSE REACTIONS) 19-453 DRIXORAL SCHERING PLOUGH ACETAMINOPHEN16-APR-96 (TABLET, MEMPHIS, TN 500MG EXTENDED RELEASE) 38151 DEXBROMPHENIRAMINE MALEATE 3MG PSEUDOEPHEDRINE SULFATE 60MG (LABELING REVISION -- PATIENT LABELING) (OTC)19-576 NIZORAL JANSSEN KETOCONAZOLE16-APR-96 (CREAM) TITUSVILLE, NJ 2% 08569 (LABELING REVISION -- ADVERSE REACTIONS) 19-648 NIZORAL JANSSEN KETOCONAZOLE16-APR-96 (CREAM) TITUSVILLE, NJ 2% 08569 (LABELING REVISION -- ADVERSE REACTIONS) 18-276 XANAX UPJOHN ALPRAZOLAM18-APR-96 (TABLET) KALAMAZOO, MI 0.25MG 49001 0.5MG 1MG 2MG (LABELING REVISION -- CLINICAL PHARMACOLOGY; CONTRAINDICATIONS; WARNINGS; PRECAUTIONS) 50-662 BIAXIN ABBOTT CLARITHROMYCIN18-APR-96 (TABLET) ABBOTT PARK, IL 250MG 60064 500MG (LABELING REVISION -- INDICATIONS AND USAGE)20-280 GENOTROPIN PHARMACIA SOMATROPIN, BIOSYNTHETIC19-APR-96 (INJECTABLE) COLUMBUS, OH 1.5MG/VIAL 43216 5.8MG/VIAL (LABELING REVISION -- HOW SUPPLIED)18-731 BUSPAR BRISTOL MYERS SQUIBB BUSPIRONE HYDROCHLORIDE22-APR-96 (TABLET) WALLINGFORD, CT 5MG 06492 10MG 15MG 30MG* (LABELING REVISION -- DESCRIPTION; ADVERSE REACTIONS; OVERDOSAGE; DOSAGE AND ADMINISTRATION; HOW SUPPLIED)19-279 DIMETANE WYETH AYERST BROMPHEMIRAMINE MALEATE22-APR-96 (SYRUP) PHILADELPHIA, PA 2MG/5ML 19101 DEXTROMETHORPHAN HYDROBROMIDE 10MG/5ML PSEUDOEPHEDRINE HYDROCHLORIDE 30MG/5ML (LABELING REVISION -- CONTRAINDICATIONS; PRECAUTIONS)* - Not marketed at this time19-010 LUPRON TAP LEUPROLIDE ACETATE24-APR-96 (INJECTABLE) DEERFIELD, IL 1MG/0.2ML 60015 (LABELING REVISION -- HOW SUPPLIED)20-186 ZIAC LEDERLE BISOPROLOL FUMARATE24-APR-96 (TABLET) PHILADELPHIA, PA 2.5MG 19101 HYDROCHLOROTHIAZIDE 6.25MG (LABELING REVISION -- OVERDOSAGE)20-186 ZIAC LEDERLE BISOPROLOL FUMARATE24-APR-96 (TABLET) PHILADELPHIA, PA 5MG 19101 HYDROCHLOROTHIAZIDE 6.25MG (LABELING REVISION -- OVERDOSAGE)20-186 ZIAC LEDERLE BISOPROLOL FUMARATE24-APR-96 (TABLET) PHILADELPHIA, PA 10MG 19101 HYDROCHLOROTHIAZIDE 6.25MG (LABELING REVISION -- OVERDOSAGE) 19-927 NIZORAL JANSSEN KETOCONAZOLE 25-APR-96 (SHAMPOO) TITUSVILLE, NJ 2% 08569 (LABELING REVISION -- OVERDOSAGE)50-708 PROGRAF FUJISAWA TACROLIMUS25-APR-96 (CAPSULE) DEERFIELD, IL EQ 1MG BASE 60015 EQ 5MG BASE (LABELING REVISION -- SECTION(S) OF LABELING REVISED NOT SPECIFIED IN APPROVAL LETTER) 50-709 PROGRAF FUJISAWA TACROLIMUS25-APR-96 (INJECTABLE) DEERFIELD, IL EQ 5MG BASE/ML 60015 (LABELING REVISION -- SECTION(S) OF LABELING REVISED NOT SPECIFIED IN APPROVAL LETTER)18-702 ACLOVATE GLAXO WELLCOME ALCLOMETASONE DIPROPIONATE26-APR-96 (OINTMENT) RES TRIANGLE PK, NC 0.05% 27709 (LABELING REVISION -- CLASS LABELING UPDATE; PRECAUTIONS)18-707 ACLOVATE GLAXO WELLCOME ALCLOMETASONE DIPROPIONATE26-APR-96 (CREAM) RES TRIANGLE PK, NC 0.05% 27709 (LABELING REVISION -- CLASS LABELING UPDATE; PRECAUTIONS)19-680 DEPAKOTE ABBOTT DIVALPROEX SODIUM26-APR-96 (CAPSULE, ABBOTT PARK, IL EQ 125MG VALPROIC ACID DELAYED RELEASE 60064 (LABELING REVISION -- PELLETS) SECTION(S) OF LABELING REVISED NOT SPECIFIED IN APPROVAL LETTER)20-363 FAMVIR SMITHKLINE BEECHAM FAMCICLOVIR26-APR-96 (TABLET) PHILADELPHIA, PA 125MG 19101 250MG 500MG (LABELING REVISION -- SECTION(S) OF LABELING REVISED NOT SPECIFIED IN APPROVAL LETTER)19-670 CLARITIN-D SCHERING LORATADINE29-APR-96 (TABLET, KENILWORTH, NJ 5MG EXTENDED RELEASE) 07033 PSEUDOEPHEDRINE SULFATE 120MG (LABELING REVISION -- SECTION(S) OF LABELING REVISED NOT SPECIFIED IN APPROVAL LETTER) 20-364 LOTREL CIBA GEIGY AMLODIPINE BESYLATE29-APR-96 (CAPSULE) SUMMIT, NJ EQ 2.5MG BASE 07901 BENAZEPRIL HYDROCHLORIDE 10MG (LABELING REVISION -- INDICATIONS AND USAGE; PRECAUTIONS; ADVERSE REACTIONS)20-364 LOTREL CIBA GEIGY AMLODIPINE BESYLATE29-APR-96 (CAPSULE) SUMMIT, NJ EQ 5MG BASE 07901 BENAZEPRIL HYDROCHLORIDE 10MG (LABELING REVISION -- INDICATIONS AND USAGE; PRECAUTIONS; ADVERSE REACTIONS)20-364 LOTREL CIBA GEIGY AMLODIPINE BESYLATE29-APR-96 (CAPSULE) SUMMIT, NJ EQ 5MG BASE 07901 BENAZEPRIL HYDROCHLORIDE 20MG (LABELING REVISION -- INDICATIONS AND USAGE; PRECAUTIONS; ADVERSE REACTIONS)10-799 DIMETAPP ALLERGY WHITEHALL BROMPHENIRAMINE MALEATE30-APR-96 (TABLET, MADISON, NJ 12MG EXTENDED RELEASE) 07940 (LABELING REVISION -- PATIENT LABELING) (OTC) ***BIOLOGICAL PRODUCT LICENSES ISSUED***1201 NONE CANGENE SOURCE PLASMA02-APR-96 (INJECTABLE) WINNIPEG, MANITOBA (A,B) CANADA1138 REVERSE-CYTE DADE AG REAGENT RED BLOOD CELLS03-APR-96 (INJECTABLE) SWITZERLAND (B)0226 NONE BLOOD BANK PLATELETS25-APR-96 (INJECTABLE) SAN BERNARDINO AND (B) RIVERSIDE COUNTIES SAN BERNARDINO, CA 92412(A) Establishment License Issued(B) Product License Issued ***BIOLOGICAL PRODUCT DEVICE APPROVALS***BK960012 CYTO-THERM-S PHOTO THERM PLASMA THAWER15-APR-96 TRENTON, NJ (C) 08610 BK960013 MTS CENTRIFUGE MICRO TYPING SYS CENTRIFUGE15-APR-96 MODEL #9310 POMPANO BEACH, FL (C) 33069BK950033 HAEMONETICS PCS2 HAEMONETICS APHERESIS HARDWARE16-APR-96 BRAINTREE, MA AND DISPOSABLE COLLECTION 02184 SET (C)(C) Substantially Equivalent ***BIOLOGICAL PRODUCT NDA APPROVAL***83-071508 PROMIT MEDISAN PHARMA DEXTRAN 115-APR-96 PARSIPPANY, NJ (D) 07054 (D) Approved ***MEDICAL DEVICE - PREMARKET APPROVAL APPLICATIONS***THE FOLLOWING DATA IS RECEIVED FROM THE CENTER FOR DEVICES AND RADIOLOGICALHEALTH AND IS NOT EDITED BY THE DIVISION OF DRUG INFORMATION RESOURCES PRIORTO PUBLICATIONP940005 ULTRAMARK 9 ADVANCED TECHNOLOGY AN ADJUNCT TO 04/11/96 HIGH DEFINITION LABORATORIES MAMMOGRAPHY AND PHYSICAL IMAGING (HDI) BOTHELL, WA BREAST EXAMINATION, TO ULTRASOUND SYSTEM 98041-3003 DIFFERENTIATE BENIGN WITH L10-5 FROM MALIGNANT OR SCANHEAD SUSPICIOUS BREAST LESIONS P940042 SOLO-CARE CIBA VISION CORP FOR CLEANING, RINSING,04/25/96 DULUTH, GA DISINFECTING AND STORING 30136-1518 SOFT (HYDROPHILIC) CONTACT LENSES AND FOR DISSOLVING ENZYME TABLETS ***MEDICAL DEVICE - PMA SUPPLEMENTALS***THE FOLLOWING DATA IS RECEIVED FROM THE CENTER FOR DEVICES AND RADIOLOGICALHEALTH AND IS NOT EDITED BY THE DIVISION OF DRUG INFORMATION RESOURCES PRIORTO PUBLICATIONN17786/S024 ALLERGAN ALLERGAN OPTICAL ALTERNATE CONTRACT 04/12/96 HYDROCARE IRVINE, CA STERILIZATION SITE, CLEANING AND 92713-9534 ISOTRON IRELAND LTD., DISINFECTING OFFALY, IRELAND, AND SOLUTION USE OF 100% ETHYLENE OXIDE TO STERILIZE PLASTIC BOTTLES, TIPS, AND CAPS N18020/S039 ALLERGAN HYDROCARE ALLERGAN OPTICAL ALTERNATE CONTRACT 04/12/96 PRESERVED SALINE IRVINE, CA STERILIZATION SITE, SOLUTION, 92713-9534 ISOTRON IRELAND LTD., SORBICARE SALINE, OFFALY, IRELAND, AND AND PRESERVED USE OF 100% ETHYLENE SALINE OXIDE TO STERILIZE PLASTIC BOTTLES, TIPS, AND CAPSN50510/S070 VITEK SYSTEMS BIOMERIEUX VITEK, INC ADDITION OF A 04/22/96 "GENERAL HAZELWOOD, MO LIMITATION STATEMENT SUSCEPTIBILITY 63042-2395 REQUIRING AN ALTERNATE CARD" METHOD OF TESTING FOR PIPERACILIN IN SUSCEPTIBILITY TESTING OF PSEUDOMONAS AERUGINOSAP790002/S016 EBI BONE ELECTRO-BIOLOGY, INC LABELING CHANGES TO04/09/96 HEALING SYSTEM PARSIPPANY, NJ PHYSICIAN INSTRUCTION 07054-1079 AND PATIENT MANUALS P790017/S052 USCI GRUNTZIG, C.R. BARD, INC STERILIZATION SITE 04/18/96 FORCE, SPRINT, BILLERICA, MA CHANGE AND A CHANGE AND SOLO BALLOON 01821 IN THE STERILIZATION DILATATION CATHETER CYCLE WITH PRO/PEL COATINGP790024/S024 EASYCLEAN/GP, ALLERGAN OPTICAL ALTERNATE CONTRACT04/12/96 LC-65, LENS CLEAR, IRVINE, CA STERILIZATION SITE AND LENS PLUS, 92715-9534 ISOTRON IRELAND LTD., DAILY CLEANERS OFFALY, IRELAND, AND USE OF 100% ETHYLENE OXIDE TO STERILIZE PLASTIC BOTTLES, TIPS, AND CAPS P800065/S014 LENS-WET ALLERGAN OPTICAL ALTERNATE CONTRACT 04/12/96 LUBRICATING AND IRVINE, CA STERILIZATION SITE REWETTING SOLUTION 92713-9534 ISOTRON IRELAND LTD., AND LENS FRESH OFFALY, IRELAND, AND LUBRICATING AND USE OF 100% ETHYLENE REWETTING DROPS OXIDE TO STERILIZE PLASTIC BOTTLES, TIPS, AND CAPS P820018/S067 AUTIMA/AURORA TELECTRONICS PACING APPROVAL FOR 04/23/96 CARDIAC PACING SYSTEMS SUBSTRATE DESIGN SYSTEM ENGLEWOOD, CO CHANGES 80112 P830026/S064 COSMOS FAMILY INTERMEDICS, INC. ALTERNATE 04/01/96 OF PULSE GENERATORS ANGLETON, TX STERILIZATION PROCESS 77515 P830056/S075 POSTERIOR CHAMBER MENTOR CORP. APPROVAL FOR MODELS 04/02/96 INTRAOCULAR LENSES SANTA BARBARA, CA C420P, C540U, C445F, (IOLS) 93111 C840U, U240F0, C540MC, U211F, AND U241FO POSTERIOR CHAMBER INTRAOCULAR LENSES VIA TIER A P840008/S053 DORNIER DORNIER MEDICAL NEW MODEL LITHOTRIPTER04/11/96 LITHOTRIPTER MOBILE SYSTEMS, INC. INDICATED FOR THE KENNESAW, GA FRAGMENTATION OF 5 TO 25 30144 MILLIMETER KIDNEY STONES SUCH AS RENAL CALYX AND AND RENAL PELVIC STONESP840024/S061 NUCLEUS 22 COCHLEAR CORP. MODIFICATIONS TO THE 04/04/96 CHANNEL COCHLEAR ENGLEWOOD, CO AUDIO INPUT SELECTOR IMPLANT SYSTEM 80112 (AIS), AN OPTIONAL ACCESSORY FOR THE NUCLEUS 22 CHANNEL COCHLEAR IMPLANT DEVICEP840068/S026 VISTA 4, 6, AND T; GUIDANT CORP. REPLACEMENT OF THE 04/16/96 DELTA T AND TRS; ST. PAUL, MN CURRENT CONNECTOR VISTA DDD; AND 55112-5798 TOP MATERIAL VIGOR DDD P850088/S033 OXYSEPT 1 ALLERGAN OPTICAL ALTERNATE CONTRACT 04/12/96 AND ULTRACARE IRVINE, CA STERILIZATION SITE DISINFECTING 92713-9534 ISOTRON IRELAND LTD., SOLUTIONS AND OFFALY, IRELAND, AND USE OXYSEPT 2 OF 100% ETHYLENE OXIDE NEUTRALIZING TO STERILIZE PLASTIC SOLUTION BOTTLES, TIPS, AND CAPSP870007/S010 SORBIC ACID OPTOPICS LABORATORIES TRANSFER OF PROCESSING04/22/96 PRESERVED STERILE CORP. SITE FOR 100% ETHYLENE SALINE FOR SOFT FAIRTON, NJ OXIDE STERILIZATION CONTACT LENSES 08320-0210 (GLEN FALLS, NY) P870026/S006 RESOLVE/GP ALLERGAN OPTICAL ALTERNATE CONTRACT 04/12/96 DAILY CLEANER IRVINE, CA STERILIZATION SITE 92715-9534 ISOTRON IRELAND LTD., OFFALY, IRELAND AND USE OF 100% ETHYLENE OXIDE TO STERILIZE PLASTIC BOTTLES, TIPS, AND CAPSP870036/S036 VERSAFLEX MEDTRONICS REVISED LABELING 04/08/96 BUCHBINDER INTERVENTIONAL OMNIFLEX PTCA SAN DIEGO, CA CATHETER SYSTEM 92121-2256 MEDTRONIC 18K, 14K, EVERGREEN, FALCON, PANTHER, AND PTCA CATHETERSP870037/S007 WET-N-SOAK ALLERGAN OPTICAL ALTERNATE CONTRACT 04/12/96 PLUS WETTING AND IRVINE, CA STERILIZATION SITE SOAKING SOLUTION 92715-9534 ISOTRON IRELAND LTD., OFFALY, IRELAND AND USE OF 100% ETHYLENE OXIDE TO STERILIZE PLASTIC BOTTLES, TIPS, AND CAPSP880003/S053 CORDIS CORDIS CORP. DEVICE MODIFICATION;04/12/96 PERCUTANEOUS MIAMI, FL NEW TRADE NAME: CORDIS TRANSLUMINAL 33102-5700 THOR PTCA CATHETER CORONARY ANGIOPLASTY (PTCA) DILATATION CATHETERS P880003/S055 CORDIS PTCA CORDIS CORP. DEVICE MODIFICATION;04/23/96 DILATATION CATHETER MIAMI, FL NEW TRADE NAME: CORDIS AND CORDIS VALOR 33102-5700 VALOR AND VALOR XL PTCA AND VALOR XL PTCA CATHETERS DILATATION CATHETERS P880003/S056 CORDIS PTCA CORDIS CORP. ADDITIONAL BALLOON SIZES04/23/96 DILATATION CATHETERS MIAMI, FL FOR THE THOR PTCA AND CORDIS THOR PTCA 33102-5700 DILATATION CATHETERS DILATATION CATHETERS (2.75MM,3.25MM, AND AND 3.75MM DIAMETERS AND 30MM LENGTHS) P880031/S009 AMO VITRAX ALLERGAN MEDICAL NEW STERILIZATION SITE04/09/96 VISCOELASTIC OPTICS (GRIFFITH MICRO SCIENCE, SOLUTION IRVINE, CA GLEN FALLS, NY) 92713-9534 NEW STERILIZATION PROCESS (100% ETHYLENE OXIDE) FOR AMO VITRAX (SODIUM HYALURONATE) IN FINAL PACKAGINGP880031/S010 AMO VITRAX ALLERGAN MEDICAL USE OF 04/08/96 (SODIUM OPTICS "PHARMACEUTICAL HYALURONATE) IRVINE, CA GRADE" SODIUM 92713-9534 HYALURONATE POWDER FROM ALTERNATE SUPPLIER P880072/S039 MODEL PA48A-OUV MEDICAL DEVELOPMENT MODELS PA48A-OUV VIA04/08/96 ULTRAVIOLET- RESEARCH, INC. TIER A MODIFICATION ABSORBING ST. PETERSBURG, FL POSTERIOR CHAMBER 33716 INTRAOCULAR LENS (IOL) P880072/S040 MODELS GL65C-OUV MEDICAL DEVELOPMENT MODELS GL65C-OUV AND04/17/96 AND PS50D-OUV RESEARCH, INC. PS50D-OUV VIA TIER A ULTRAVIOLET- ST. PETERSBURG, FL MODIFICATION ABSORBING 33716 POSTERIOR CHAMBER INTRAOCULAR LENSES (IOLS) P880072/S042 POSTERIOR CHAMBER MEDICAL DEVELOPMENT APPROVAL FOR TIER A 04/24/96 INTRAOCULAR LENSES RESEARCH, INC. POSTERIOR CHAMBER MODELS PA38E-OUV ST. PETERSBURG, FL INTRAOCULAR LENSES AND PL52A-OUV 33716 MODELS PA38E-OUV AND PL52A-OUVP880098/S009 SF-P MENICON CO., LTD. LABELING CHANGES 04/03/96 (MELAFOCON A) WASHINGTON, D.C. ADDITION OF ALLERGAN, RIGID GAS PERMEABLE 20005 INC.'S DESTAT 4 SYSTEM CONTACT LENS FOR AND ALCON LABORATORIES, EXTENDED WEAR INC.'S OPTI-SOAK SYSTEM P890025/S009 TDX/TDXFLX ABBOTT LABORATORIES NEW PROBE CLEANING 04/01/96 CYCLOSPORINE ABBOTT PARK, IL PROCEDURE MONOCLONAL 60064-3500 WHOLE BLOODP890027/S030 NUCLEUS 22 COCHLEAR CORP. MODIFICATIONS TO THE 04/04/96 CHANNEL COCHLEAR ENGLEWOOD, CO AUDIO INPUT SELECTOR IMPLANT 80112 (AIS), AN OPTIONAL ACCESSORY FOR THE NUCLEUS 22 CHANNEL COCHLEAR IMPLANT DEVICEP900009/S002 SONIC ACCELERATED EXOGEN, INC. NEW MANUFACTURING 04/02/96 FRACTURE HEALING PISCATAWAY, NJ FACILITY WHICH IS SYSTEM MODEL 2A 08855 OWNED AND OPERATED BY HI-TRONICS DESIGNS, INC., AND LOCATED AT HACKETTSTOWN, NJ P900047/S003 WET-N-SOAK ALLERGAN OPTICAL ALTERNATE CONTRACT 04/12/96 REWETTING DROPS IRVINE, CA STERILIZATION SITE 92713-9534 ISOTRON IRELAND LTD., OFFALY, IRELAND, AND USE OF 100% ETHYLENE OXIDE TO STERILIZE PLASTIC BOTTLES, TIPS, AND CAPS P900056/S015 ROTABLATOR HEART TECHNOLOGY, INC. ELIMINATION OF THE 04/23/96 ROTATIONAL REDMOND, WA USP MOUSE SAFETY TEST ANGIOPLASTY SYSTEM 98052-3376 AS A STERILIZATION LOAD RELEASE CRITERIA P900061/S013 MODEL 7219 B/D/E MEDTRONIC, INC. APPROVAL FOR MODEL 04/15/96 JEWEL, MODEL 7202 MINNEAPOLIS, MN 7219 B/D/E JEWEL, D/E JEWEL, MODEL 55432-3576 MODEL 7202 D/E/ 7220 B/D/E JEWEL JEWEL, MODEL 7220 PLUS DEVICE USED B/D/E JEWEL PLUS WITH CPI ENDOTAK DEVICE WITH ENDOTAK SERIES LEADS SERIES LEADSP910023/S016 CADENCE TIERED VENTRITEX, INC. APPROVAL TO STERILIZE04/26/96 THERAPY SUNNYVALE, CA VENTRITEX PRODUCTS AT DEFIBRILLATOR 94086-6527 SOREX MEDICAL, INC., SYSTEM USING CHAMBER 9P910073/S016 ENDOTAK SQ LEAD GUIDANT CORP. ALTERNATIVE 04/04/96 ARRAY MODEL 0048 ST. PAUL, MN MANUFACTURING SITE: AND ENDOTAK SQ 55112-5798 CARDIAC PACEMAKERS, LEAD PATCH INC., DEL CARIBE, MODEL 0063 ROAD 698 LOT NO. 12, DORADO, PUERTO RICO 00646P910073/S018 LEAD ADAPTER GUIDANT CORP. APPROVAL FOR LEAD 04/02/96 MODELS 6024, ST. PAUL, MN ADAPTER MODELS 6024, 6833, AND 6931 55112-5798 6833, 6931P910073/S019 MODEL 6952 LEAD GUIDANT CORP. MODEL 6952 LEAD 04/01/96 EXTENDER ST. PAUL, MN EXTENDER 55112-5798P910075/S005 COMPLETE BRAND ALLERGAN OPTICAL ALTERNATE CONTRACT 04/12/96 MULTI-PURPOSE IRVINE, CA STERILIZATION SITE SOLUTION AND 92713-9534 ISOTRON IRELAND LTD., COMPLETE BRAND OFFALY, IRELAND, AND USE LUBRICATING AND OF 100% ETHYLENE OXIDE REWETTING DROPS TO STERILIZE PLASTIC BOTTLES, TIPS, AND CAPS P920014/S003 TCI HEARTMATE THERMO CARDIOSYSTEMS, CHANGE IN THE DESIGN 04/12/96 IP LVAS INC. OF THE NON-BLOOD WOBURN, MA CONTACTING TITANIUM 01888-2697 COMPONENTS USED IN THE INFLOW AND OUTFLOW VALVE CONDUITS AND IN THE OUTFLOW GRAFT CONDUIT P920015/S009 MEDTRONIC MEDTRONIC, INC. APPROVAL FOR THE 04/08/96 MODEL 6707 MINNEAPOLIS, MN MODEL 6707 ADAPTER ADAPTER 55432-3576P920032/S002 MICRO-PACE PACE MEDICAL, INC. APPROVAL FOR THE 04/26/96 MODEL 4553 WALTHAM, MA PACESETTER, INC., DUAL DDD 02154 MODEL 3070B PRIVATE CHAMBER TEMPORARY LABEL VERSION OF THE CARDIAC PACEMAKER PACE MEDICAL MODEL 4575P930012/S001 PROGRESSIVE PROGRESSIVE USE OF 100% ETHYLENE 04/02/96 ANGIOPLASTY ANGIOPLASTY SYSTEMS OXIDE STERILIZATION SYSTEMS (PAS) MENLO PARK, CA TO BE PERFORMED AT LACROSSE PTCA 94025 MEDICAL MANUFACTURING CORONARY CORP., ERIE, PA DILATATION CATHETER P930012/S002 PROGRESSIVE PROGRESSIVE ADDITION OF 1.5MM 04/16/96 ANGIOPLASTY ANGIOPLASTY SYSTEMS DIAMETER, 20 MM SYSTEMS (PAS) MENLO PARK, CA LENGTH BALLOON; LACROSSE PTCA 94025-1516 ADDITION OF 2.5MM, CORONARY 3.0MM, AND 4.0MM DILATATION CATHETER BALLOONS P940034/S001 GENPROBE GEN-PROBE INC. COMPONENT, SHELF 04/23/96 AMPLIFIED SAN DIEGO, CA LIFE, AND LABELING MYCOBACTERIUM 92121 CHANGES; NEW VENDOR TUBERCULOSIS OF REVERSE DIRECT (MTD) TEST TRANSCRIPTASEP950009/S001 AUTOPAP 300 QC NEOPATH, INC. CHANGE IN MANUAL TO 04/25/96 SYSTEM REDMOND, WA IMPROVE HOW THE REPORT 98052 FORMS WILL LOOK, FOR CLARITY ***ORIGINAL VETERINARY NADAs***141-043 SYNOVEX PLUS CATTLE SYNTEX AN HLTH ESTRADIOL BENZOATE22-FEB-96 (EAR IMPLANT) PALO ALTO, CA 2.5MG 94304 TRENBOLONE ACETATE 25MG ***ORIGINAL ABBREVIATED VETERINARY NADAs***200-170 NICARMIX 25 BROILER PLANALQUIMICA IND LTDA LINCOMYCIN02-APR-96 3-NITRO CHICKENS SAO PAULO, BRAZIL HYDROCHLORIDE LINCOMIX 4,20,50GM/LB (TYPE A MEDICATED NICARBAZIN ARTICLES) 113.5GM/LB ROXARSONE 10,20,50,80%200-171 NICARMIX 25 BROILER PLANALQUIMICA IND LTDA LINCOMYCIN02-APR-96 LINCOMIX CHICKENS SAO PAULO, BRAZIL HYDROCHLORIDE (TYPE A MEDICATED 4,20,50GM/LB ARTICLES) NICARBAZIN 113.5GM/LB200-172 NICARMIX 25 BROILER PLANALQUIMICA IND LTDA NICARBAZIN02-APR-96 3-NITRO CHICKENS SAO PAULO, BRAZIL 113.5GM/LB (TYPE A MEDICATED ROXARSONE ARTICLES) 10,20,50,80% ***SUPPLEMENTAL VETERINARY NADAs***140-971 HEARTGARD-300 PLUS DOGS MERCK IVERMECTIN15-FEB-96 (TABLET) RAHWAY, NJ 68MCG 07065 PYRANTEL PAMOATE 57MG
|




